Fiche centre
Clinical Neuroscience Solutions, Inc.
Memphis — United States
Essais liés3clinical trials
VilleMemphislocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03939312
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Atogepant | Migraine | Phase 3 | NCT03939312 | Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine | COMPLETED |
| Corabotase | Migraine | Phase 2 | NCT06625060 | MERANTI — A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults | ACTIVE_NOT_RECRUITING |
| TNX-1900 | Migraine | Phase 2 | NCT05679908 | PREVENTION — A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine | COMPLETED |